Concourse Financial Group Securities, Inc. Aclaris Therapeutics, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.67 Billion
Q4 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share
Q4 2024 Feb 13, 2025	BUY	$1.15 - $4.59 $0 - $0
Q3 2024 Oct 10, 2024	BUY	$1.12 - $1.4 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$1.01 - $1.36 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$0.92 - $1.44 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$0.64 - $6.49 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$6.56 - $10.95 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$6.56 - $10.95 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$7.89 - $10.64 $0 - $0
Q1 2023 May 15, 2023	BUY	$7.07 - $17.95 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$14.33 - $18.37 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$13.07 - $18.22 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$10.16 - $17.08 $0 - $0
Q1 2022 May 09, 2022	BUY	$9.74 - $17.92 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$12.27 - $18.49 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$13.38 - $18.8 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$17.08 - $29.6 $0 - $0
Q1 2021 May 13, 2021	BUY	$5.86 - $27.73 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$2.65 - $7.61 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$1.5 - $2.71 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$1.04 - $1.73 $0 - $0
Q1 2020 May 13, 2020	BUY	$0.75 - $2.18 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$1.02 - $1.97 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$0.79 - $2.47 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$2.13 - $7.06 $0 - $0
Q1 2019 May 15, 2019	BUY	$5.63 - $7.84 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$6.3 - $15.4 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$14.38 - $20.89 $0 - $0

Others Institutions Holding ACRS

# of Institutions

106

Shares Held

87.8M

Call Options Held

293K

Put Options Held

124K

Bml Capital Management, LLC Zionsville, IN

14.3M
Shares

$28.4 Million
21.95% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

9.63M
Shares

$19.2 Million
0.04% of portfolio
Vivo Capital, LLC Palo Alto, CA

8.89M
Shares

$17.7 Million
4.3% of portfolio
Rock Springs Capital Management LP Baltimore, MD

6.2M
Shares

$12.3 Million
0.61% of portfolio
Ra Capital Management, L.P. Boston, MA

4.67M
Shares

$9.29 Million
0.19% of portfolio

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $133M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account